Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy

Immunotherapy is a milestone in the treatment of poor-prognosis pediatric acute lymphoblastic leukemia (ALL) and is expected to improve treatment outcomes and reduce doses of conventional chemotherapy without compromising the effectiveness of the therapy. However, both chemotherapy and immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Śliwa-Tytko, Patrycja, Kaczmarska, Agnieszka, Lejman, Monika, Zawitkowska, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146746/
https://www.ncbi.nlm.nih.gov/pubmed/35628334
http://dx.doi.org/10.3390/ijms23105515

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146746/
https://www.ncbi.nlm.nih.gov/pubmed/35628334
http://dx.doi.org/10.3390/ijms23105515

Ejemplares similares